The sleep state-dependent midlatency auditory evoked P50 potential in various disorders
暂无分享,去创建一个
John L. Dornhoffer | Ergun Y. Uc | Robert D. Skinner | E. Garcia-Rill | R. Skinner | E. Uc | J. Dornhoffer | J. Clothier | Edgar Garcia-Rill | J. Clothier | Alice V. Fann | Noriaki Mamiya | A. Fann | N. Mamiya
[1] R Freedman,et al. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. , 1983, Biological psychiatry.
[2] E. Garcia-Rill,et al. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat , 1999, Neuroscience.
[3] M. Kraut,et al. Object Activation from Features in the Semantic System , 2002, Journal of Cognitive Neuroscience.
[4] J. Buchwald,et al. Depth evoked potential and single unit correlates of vertex midlatency auditory evoked responses , 1983, Brain Research.
[5] W. Ritter,et al. The sources of auditory evoked responses recorded from the human scalp. , 1970, Electroencephalography and clinical neurophysiology.
[6] Robert Freedman,et al. Auditory sensory gating in hippocampal neurons: A model system in the rat , 1990, Biological Psychiatry.
[7] D. Paré,et al. Fast oscillations (20-40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] E Garcia-Rill,et al. Decreased habituation of midlatency auditory evoked responses in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[9] S. Folstein,et al. Locus coeruleus involvement in Huntington's disease. , 1992, Archives of neurology.
[10] J S Buchwald,et al. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. , 1991, Electroencephalography and clinical neurophysiology.
[11] E. Garcia-Rill,et al. The pedunculopontine nucleus—Auditory input, arousal and pathophysiology , 1995, Progress in Neurobiology.
[12] Jane S. Paulsen,et al. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[13] P S Cowings,et al. Promethazine as a motion sickness treatment: impact on human performance and mood states. , 2000, Aviation, space, and environmental medicine.
[14] E. Garcia-Rill,et al. Midlatency auditory evoked potentials and the startle response in the rat , 1996, Neuroscience.
[15] E. Mohr,et al. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases , 1996, Acta neurologica Scandinavica.
[16] E Garcia-Rill,et al. Disorders of the reticular activating system. , 1997, Medical hypotheses.
[17] E. Garcia-Rill,et al. A middle-latency auditory-evoked potential in the rat , 1995, Brain Research Bulletin.
[18] G. Rose,et al. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating , 1991, Brain Research.
[19] R Freedman,et al. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.
[20] E. Garcia-Rill,et al. Sensory gating of the P13 midlatency auditory evoked potential and the startle response in the rat , 1999, Brain Research.
[21] T. Allison,et al. Somato-sensory evoked responses in patients with unilateral cerebral lesions. , 1970, Electroencephalography and clinical neurophysiology.
[22] Z. Kevanishvili,et al. Human slow auditory evoked potentials during natural and drug-induced sleep. , 1979, Electroencephalography and clinical neurophysiology.
[23] C. C. Wood,et al. Scalp distribution of human auditory evoked potentials. II. Evidence for overlapping sources and involvement of auditory cortex. , 1982, Electroencephalography and clinical neurophysiology.
[24] E. Garcia-Rill,et al. Locus coeruleus involvement in the effects of immobilization stress on the P13 midlatency auditory evoked potential in the rat , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[25] R. Knight,et al. Bitemporal lesions dissociate auditory evoked potentials and perception. , 1984, Electroencephalography and clinical neurophysiology.
[26] E. Garcia-Rill,et al. Auditory input to the pedunculopontine nucleus: I. Evoked potentials , 1995, Brain Research Bulletin.
[27] A. Graybiel,et al. Sopite syndrome: a sometimes sole manifestation of motion sickness. , 1976, Aviation, space, and environmental medicine.
[28] Robert Freedman,et al. Cholinergic gating of response to auditory stimuli in rat hippocampus , 1992, Brain Research.
[29] E. Garcia-Rill,et al. The P1: insights into attention and arousal. , 1994, Pediatric neurosurgery.
[30] M Reite,et al. Source location of a 50 msec latency auditory evoked field component. , 1988, Electroencephalography and clinical neurophysiology.
[31] P. Reiner,et al. Noradrenaline hyperpolarizes identified rat mesopontine cholinergic neurons in vitro , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] R. Sprengelmeyer,et al. The pattern of attentional deficits in Huntington's disease. , 1995, Brain : a journal of neurology.
[33] J S Buchwald,et al. Midlatency auditory evoked responses: differential recovery cycle characteristics. , 1986, Electroencephalography and clinical neurophysiology.
[34] D. Contreras,et al. Synchronization of fast (30-40 Hz) spontaneous cortical rhythms during brain activation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] A. Belger,et al. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating , 1999, Biological Psychiatry.
[36] J. Meltzer,et al. Disruption of sensory gating by the α2 selective noradrenergic antagonist yohimbine , 1993, Biological Psychiatry.
[37] R. E. Marshall,et al. Polarities and field configurations of the vertex components of the human auditory evoked response: a reinterpretation. , 1971, Electroencephalography and clinical neurophysiology.
[38] J S Buchwald,et al. Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease. , 1989, Electroencephalography and clinical neurophysiology.
[39] R. Erwin,et al. Midlatency auditory evoked responses: P1 abnormalities in adult autistic subjects. , 1992, Electroencephalography and clinical neurophysiology.
[40] A E Rosser,et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. , 1998, Brain : a journal of neurology.
[41] E. Garcia-Rill,et al. Serotonergic modulation of the P13 midlatency auditory evoked potential in the rat , 2000, Brain Research Bulletin.
[42] E. Garcia-Rill,et al. Midlatency auditory-evoked potentials in the rat: effects of interventions that modulate arousal , 1999, Brain Research Bulletin.
[43] M. Dose,et al. Nocturnal sleep in huntington's disease , 1991, Journal of Neurology.
[44] E. Garcia-Rill,et al. Cholinergic modulation of the sleep state-dependent P13 midlatency auditory evoked potential in the rat , 2000, Brain Research.
[45] J. Buchwald,et al. Cholinergic neurons of the feline pontomesencephalon. I. Essential role in ‘Wave A’ generation , 1990, Brain Research.
[46] P. Hansotia,et al. Sleep disturbances and severity of Huntington's disease , 1985, Neurology.
[47] M. Szuba,et al. Depression, sleep physiology, and antidepressant drugs , 2001, Depression and anxiety.
[48] E. Garcia-Rill,et al. Auditory input to the pedunculopontine nucleus: II. Unit responses , 1995, Brain Research Bulletin.
[49] E. Garcia-Rill,et al. Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder , 1999, Depression and anxiety.
[50] G. V. Simpson,et al. Multiple brain systems generating the rat auditory evoked potential. II. Dissociation of auditory cortex and non-lemniscal generator systems , 1993, Brain Research.
[51] R. Llinás,et al. The neuronal basis for consciousness. , 1998, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[52] E. Seifritz. Contribution of Sleep Physiology to Depressive Pathophysiology , 2001, Neuropsychopharmacology.